Hereditary thrombophilias - Recommendations for genetic testing in the clinical praxis;Dědičné trombofilie - Doporučení k provádění genetických testů v klinické praxi

Casopis Lekaru Ceskych

Volumn 149, Issue 10, 2010, Pages 468-471

  Kvasnička, Jan ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Genetic tests; Guidelines; Hereditary; Thrombophilia

Indexed keywords

GENETIC SCREENING; GENETICS; HUMAN; REVIEW; THROMBOPHILIA;

GENETIC TESTING; HUMANS; THROMBOPHILIA;

EID: 78149352116     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Cohen AT, Agnelli G, Anderson FA, et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007; 98: 756-764.
2. Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol 2007; 44: 62-69.
3. Port SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3'- untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-3703.
4. Sousa NC, Anicchino-Bizzacchi JM, Locatelli MF, Castro V, Barjas-Castro ML. The relationship between ABO groups and subgroups, factor VIII and von Willebrand factor. Haematologica 2007; 92: 236-239.
5. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999; 353: 1167-1173.
6. Mansveit EP, Faffan M, McVey JH, Tuddenham EG. Analysis of F 8 gene in individuals with high plasma factor VIII: C levels and associated venous thrombosis. Thromb Haemostas 1998; 80: 561-565.
7. Kyrle PA, Minar E, Hirschl M, et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med 2000; 243: 457-462.
8. Gohil R, Peck G, Sharma P. The genetics of venous thromboembolism.A meta-analysis involving 120,000 cases and 180,000 controls. Thromb Haemostas 2009; 102: 360-370.
9. Tybjaerg-Hansen A, Agerholm-Larsen B, Humphries SE, et al. A common mutation (G455-A) in the β-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9, 127 individuals based on the Copenhagen City Heart Study. J Clin Invest 1997; 99: 3034-3038.
10. Kvasnička J, Kvasnička J jr. Trombofilie a trombotické stavy v klinické praxi. Praha: Grada Publishing 2003; s. 300.
11. Meijers JCM, Tekelenburg WLH, Bouma BN, et al. High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med 2000; 342: 696-701.
12. van Hylckama V, Lieg A, van der Linden IK, et al. High levels of factor IX increase the risk of venous thrombosis. Blood 2000; 95: 3678-3682.
13. Geerts WH, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW; American College of Chest Physicians. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (Suppl): 381-453.
14. Beauchamp NJ, Makris M, Preston FE, et al. Major structural defects in the antithrombin gene in four families with type I antithrombin deficiency. Partial /complete deletions and rearrangement of the antithrombin gene. Thromb Haemost 2000; 83: 715-721.
15. Bertina RM, Koeleman PC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van derVelden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67.
16. Björgell O, Nilsson PE, Nilsson J-A, et al. Location and extent of deep vein thrombosis in patients with and without FV : R 506Q mutation. Thromb Haemost 2000; 83: 648-651.
17. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-118.
18. Wu O, Robertson L, Twaddle S, et al. Screening for thrombophilia in high-risk situations: systematic review and costeffectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS). Health Technol Assess 2006; 10 (11): 1-110.
19. Morris ST, Jardine AG. The vascular endothelium in chronic renal failure. J Nephrol 2000; 13: 96-105.
20. Bauer KA. The hypercoagulable states. In: Disorders of hemostasis. Ratnoff OD, Forbes ChD eds. Philadelphia: Saunders Co 1996; s. 228-258.